Shardul Kulkarni of Angel Broking is of the view that, good strong move is expected in Glenmark Pharma in the near term, so one can look at buying opportunity in the stock at Rs 510 or on declines.
first published: Dec 26, 2012 03:04 pm
A collection of the most-viewed Moneycontrol videos.

New Year Party Or Year-End Blues? Bulls In Focus| Top Stock Bets & 2026 Outlook| Opening Bell Live

Nifty Trades in a Narrow 100-Point Range on 2025’s Final F&O Expiry | Closing Bell Live

Small-Caps & Risk: What Investors Often Miss

Nifty’s Best Case Target & Top Stock Bets For 2026| IPO Wave Set To Get Bigger| Opening Bell Live
You are already a Moneycontrol Pro user.

